在小鼠中,CFTR调节器Elexacaftor和Ivacaftor对神经行为的影响不同
bioRxiv : the preprint server for biology
|July 9, 2025
概括
像Trikafta这样的新型囊性纤维化 (CF) 药物可能会引起焦虑和抑郁. 这项研究发现,elexacaftor在小鼠中引起了类似焦虑的行为,而ivacaftor在小鼠中引起了类似抑郁的行为,支持了患者的报告.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 最近CFTR调节器疗法的进展,如elexacaftor-tezacaftor-ivacaftor (Trikafta),已经显著改善了囊性纤维化 (CF) 患者的治疗结果.
- 新兴的临床观察表明,这些CFTR调节剂与包括焦虑和抑郁症在内的不良神经精神病学影响之间存在潜在联系.
- 这些报告的副作用背后的精确机制在很大程度上仍未被探索.
研究的目的:
- 在动物模型中研究关键CFTR调节器组件elexacaftor和ivacaftor的临床前神经行为影响.
- 探索CFTR在与情绪调节相关的大脑区域中的存在和潜在作用.
主要方法:
- 对小鼠进行急性给予elexacaftor和ivacaftor.
- 使用已建立的行为范式评估类似焦虑和类似抑郁的行为.
- 在脑组织中Cftr mRNA表达的定量分析,特别是杏仁体和海马体.
主要成果:
- 在小鼠中,Elexacaftor的使用导致了类似焦虑的行为显著增加.
- 艾瓦卡夫托尔的使用在动物模型中诱导了类似抑郁的行为.
- 在杏仁体和海马体中检测到CftrmRNA,这些大脑区域对于情绪处理和情绪控制至关重要.
结论:
- 这些临床前发现为CFTR调节器治疗患者所报告的焦虑和抑郁症提供了生物学可信性.
- 该研究强调了CFTR在中枢神经系统中的存在和潜在的功能相关性.
- 对CFTR在神经生物学中的作用的进一步研究可能会为开发下一代CF疗法提供信息,这些疗法具有优化的神经精神病学安全概况.
更多相关视频
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.4K
08:55Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
Published on: July 4, 2018
7.9K
相关概念视频
Cystic Fibrosis: Pathogenesis
369
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
369
Cystic Fibrosis: Management
227
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
227
